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Abstract  19 
Advances in next generation sequencing technologies and the application of 20 
metagenomic approaches have fuelled an exponential increase in our understanding 21 
of the human gut microbiome. These approaches are now also illuminating features 22 
of the diverse and abundant collection of viruses (termed the virome) subsisting with 23 
the microbial ecosystems residing within the human holobiont. Here we focus on the 24 
current and emerging knowledge of the human gut virome, with a particular focus on 25 
viruses infecting bacteria (bacteriophage or phage), which are a dominant component 26 
of this viral community. We summarise current insights regarding the form and function 27 
of this ‘human gut phageome’ and highlight promising avenues for future research. In 28 
doing so we discuss the potential for phage to drive ecological functioning and 29 
evolutionary change within this important microbial ecosystem, their contribution to 30 
modulation of host-microbiome interactions and stability of the community as a whole, 31 
as well as the potential role of the phageome in human health and disease. We also 32 
consider the emerging concepts of a ‘core healthy gut phageome’ and the putative 33 
existence of ‘viral enterotypes’ and ‘viral dysbiosis’.   34 
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Introduction 35 
 36 
In the last decade we have seen an exponential increase in our understanding of the 37 
human microbiome, which may be defined as the collection of microbes associated 38 
with the human body and their genetic content. The acceleration in our understanding 39 
of this ecosystem has been largely fuelled by advances in next generation sequencing 40 
technologies, and the application of metagenomic approaches. These new tools allow 41 
detailed, culture-independent, interrogation of the human-microbial landscape at an 42 
unprecedented scale, enabling the biological significance and diversity of these human 43 
associated microbial communities to be uncovered (1–8).  44 
 45 
One of the most well-characterised and densely populated areas of the human 46 
microbiome is the adult human gastrointestinal tract. Approximately 1013 bacterial cells 47 
(9) and an average of ~160 distinct species may reside in the adult human alimentary 48 
tract (predominantly in the colon), with over 1000 different bacterial species in total 49 
associated with the human gut microbiome (5). The gut microbial community is now 50 
accepted to be intimately involved in our health and well-being, providing a range of 51 
beneficial functions such as extraction of additional energy from our diet, shaping the 52 
development of our immune systems, providing protection from invading pathogens, 53 
and has emerging roles in modulating mood, behaviour, neurocognitive development, 54 
and even the ageing process (1–4,8,10–15). Imbalances in the make-up of the gut 55 
microbiome - also termed dysbiosis – is now increasingly linked with a wide spectrum 56 
of diseases and disorders (both gut associated and those relating to extra-intestinal 57 
organ systems). These range from Inflammatory bowel diseases and cancer, to 58 
metabolic disorders, obesity, and even autism and Alzheimers (16,17). Emphasis is 59 
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now being placed on delineating whether dysbiosis of the microbiome is a cause or 60 
consequence of some of these diseases, and how manipulation of the gut microbiome 61 
may aid prophylaxis, diagnosis, or treatment (18,19). 62 
 63 
However, as with microbial ecosystems extant in other habitats, the gut microbiome is 64 
itself host to another less well studied and explored community of non-cellular 65 
microbes. Metagenomic sequencing efforts are also now revealing the range of 66 
viruses associated with the human gut microbiome, termed the human gut virome 67 
(20,21). This viral community encompasses an abundant and diverse collection of 68 
viruses that infect every domain of life (Eukaryota, Archaea, and Bacteria), but 69 
perhaps not surprisingly, is dominated by viruses that infect and replicate within 70 
bacterial cells (bacteriophage or phage) (20,21). Because of this dominance of phage, 71 
the term “phageome” is often used to refer specifically to the bacteriophage fraction of 72 
the gut virome. 73 
 74 
Although the study of the gut virome or phageome is far less advanced than that of 75 
the underlying microbiome, a range of important roles and functions have already been 76 
attributed to phage in non-host associated bacterial ecosystems (e.g. marine or 77 
freshwater environments), which are likely to also apply in some shape or form to the 78 
gut virome. These include the transfer of genes between different bacterial strains or 79 
species, modulation of community structure and corresponding functional outputs, and 80 
provision of accessory functions that directly benefit bacterial hosts (22–24). In the 81 
context of host-associated microbial ecosystems, the capacity of phage to endow 82 
bacterial hosts with new abilities is of additional significance when traits that may 83 
directly impact host health are considered, including toxin synthesis, production of 84 
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virulence factors and antibiotic resistance genes (20,21,25–32). More generally, the 85 
ability to infect and kill their bacterial hosts also give phage the potential to modulate 86 
bacterial community structure and destabilise the gut microbiome, which may in turn 87 
diminish or obviate benefits provided by the gut microbiome, or lead to deleterious 88 
host-microbe interactions (23,33,34). In contrast, recent research is also revealing how 89 
phage within the gut virome may play important fundamental functions in microbiome 90 
maintenance and recovery from antibiotic perturbation, and the potential for these 91 
viruses to enter direct symbiotic relationships with the higher human host (31,35,36).  92 
 93 
As the role of the virome in the development and functioning of the gut microbial 94 
community is starting to be uncovered, evidence is accumulating that this viral 95 
community also reflects the co-evolution of host and microbe within the gut, driving 96 
diversity and functionality, and that specific phage may be unique to or enriched within 97 
the gut ecosystem (23,34,37–40). Recognition of these attributes and the potential of 98 
phage to drive ecological functioning and evolutionary change (23,34,37,39,40), has 99 
understandably ignited interest in investigating the role of these prokaryotic viruses 100 
within the human gut virome and as part of the human gut microbiome as a whole. It 101 
is also fitting that the concept of dysbiosis, and the impacts of such perturbations on 102 
human health, have begun to be considered from the perspective of the virome or 103 
phageome, and there is a growing consensus that this concept should also be 104 
extended to the phage component of the gut ecosystem (see reviews by (41–43). Here 105 
we review current knowledge of the human gut virome (with a particular focus on the 106 
phageome), and summarise new insights into its form and function.  107 
 108 
Virome Structure and ecological dynamics 109 
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In recent years, studies of the human gut virome have mainly focused on the analysis 110 
of virus like particles (VLPs) purified from faecal samples, and the application of high 111 
throughput metagenomic approaches to characterise these (20,21,44,45). These 112 
studies have provided much insight into the diversity and structure of the gut virome, 113 
which is likely to reflect the underlying diversity of the bacterial microbiome (5).  114 
 115 
Our current knowledge indicates the bacteriophage component of the gut virome (or 116 
the phageome) to be dominated by double stranded DNA phages of the order 117 
Caudovirales (Podoviridae, Siphoviridae, and Myoviridae) as well as the single 118 
stranded DNA containing members of the family Microviridae (20,21). These key 119 
virotypes mostly infect bacteria belonging to the most prevalent phyla within the gut, 120 
comprising members of the Firmicutes, Bacteroidetes, Proteobacteria and 121 
Actinobacteria (42). RNA viruses have also been identified, but these appear to 122 
represent only a minor fraction of the viral community based on available studies, and 123 
are thought to be mainly allocthonous plant infecting viruses ingested with food, rather 124 
than perhaps true constituents of the gut virome (27). The adult gut virome may be 125 
dominated by just one or a few different virotypes (20,21) and is characterised by a 126 
high degree of stability in terms of its structure over time, with temporal tracking of gut 127 
virotypes revealing the retention of between 80 to 95% of virotypes over a period of 128 
one to 2.5 years (20,21).  129 
In terms of diversity, available estimates suggest a healthy human gut is populated by 130 
between 35-2800 actively replicating viruses (46), but that phage genome diversity is 131 
lower in the gut compared to environments such as the ocean or hot springs and even 132 
within other host associated sites, such the lung and oral cavity (47).  133 
 134 
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A large proportion of sequences identified in metagenomic surveys, however, are 135 
without close homologues within public databases, reflecting the largely 136 
uncharacterised nature of the phage gene-space in most microbial habitats, including 137 
the mammalian gut. In terms of the gut phageome specifically, the novelty inherent in 138 
this viral community was clearly highlighted in the landmark study published by Reyes 139 
and co-workers, where approximately 80% of reads lacked notable homology to 140 
known viruses in public repositories (20).  141 
 142 
In contrast to other environments, in which phage are known to outnumber their 143 
bacterial hosts by an order of magnitude (22), phage are thought to exist at more 144 
equitable ratios within the human gut (20), with an estimated 109-1012 VLPs (48,49) in 145 
comparison to an estimated 1011 bacteria per gram of faecal material (9,50). However, 146 
phage can accumulate to higher densities at mucosal surfaces, significantly 147 
outnumbering their hosts in these niches (approximately 20:1 in the murine intestine) 148 
(35). Recent work is also revealing that, as with characterisation of the microbiome in 149 
general, extraction protocols may influence the estimation of VLP numbers as well as 150 
delineation of community structure derived from subsequent high throughput 151 
sequencing efforts (48,49). This is also highlighted by studies that have shown 152 
significant fractions of the gut phageome may be accessed via the analyses of 153 
conventional metagenomic datasets, which are based on the extraction and 154 
sequencing of bacterial DNA (21,32,51,52). Studies of the gut phageome through 155 
these alternative approaches to VLP analysis, have also suggested that standard 156 
metagenomes may provide access to particular groups of phage not well represented 157 
by VLP-based libraries, which will presumably be dominated by actively replicating 158 
phage (32,41). 159 
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 160 
Metagenomic analyses have also provided insight into the lifestyles of human gut 161 
phage, and provided evidence that the human gut phageome is largely composed of 162 
temperate phage, as indicated by the frequency of integrase genes in human gut viral 163 
metagenomes (20,21). Temperate phage undergo a lysogenic cycle of reproduction, 164 
where phage genetic material is integrated into the genome of bacterial hosts cells to 165 
form a dormant prophage, or persists as a dormant episomal element, and replicated 166 
with the host genome during bacterial reproduction. The potential dominance of 167 
temperate phage in the gut has led to hypotheses that the “piggyback-the-winner” 168 
model of phage ecological dynamics pervades in the human gut virome (53,54), in 169 
which lysogenic replication is predicted to dominate under conditions of high nutrient 170 
availability and bacterial growth. This is in stark contrast to non-host associated 171 
environments, in which virulent phage and lytic reproduction appear to dominate, 172 
leading to ‘kill the winner’ (or Lotka-Volterra) phage-host dynamics, that manifest as 173 
lagged boom-bust cycles of phage-host abundance (55,56).  174 
 175 
When considered from an evolutionary perspective, the proposed dominance of 176 
temperate phage in the gut community is congruent with the reported stability of the 177 
gut microbiome in adults (20,21,57,58), and the top-down selective pressure for a 178 
functionally stable gut microbiome that is hypothesised to be exerted by the higher 179 
mammalian host (4). However, a dominance of temperate, lysogenic phage is also in 180 
line with studies that have shown access to novel fractions of the phageome through 181 
interrogation of metagenomic datasets derived from bacterial DNA extracts (32,51,52). 182 
 183 
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Other models of phage ecological dynamics may also be of relevance to the gut 184 
virome, which include “fluctuating-selection-dynamics” (FSD) and “arms-race-185 
dynamics” (ARD) (39,59–61). In the FSD model bacteria and phage populations 186 
continually fluctuate though lagged cycles of expansion and contraction, but without 187 
total elimination of phage hosts, and instead bacterial diversity is maintained and 188 
stable phage communities are established, which is also congruent with features of 189 
the gut virome (39,59–61). In contrast, ARD are evident in the co-evolution of lytic 190 
phage with host bacteria, in which development of host defence systems to avoid 191 
predation by phage are continually countered by reciprocal developments of new 192 
infection strategies in phage, leading to what has been termed an evolutionary arms 193 
race (39,59). Given the apparent dominance of temperate phage in the human gut 194 
virome, ARD seems less likely to be a major ecological dynamic in the human gut 195 
habitat, but may be relevant to a limited number of specific host-phage systems, or 196 
during situations where bacterial diversity is reduced and underlying ecology of the 197 
microbiome altered with respect to the stable adult community. This may include 198 
situations such as dysbiosis during disease, and conceivably the infant or elderly gut 199 
communities. Readers are directed to excellent reviews (39,59) for more in-depth 200 
analysis of phage-bacterial dynamics and effects on the diversity and structure of this 201 
ecosystem. 202 
 203 
Inter-personal variation and potential for ‘viral enterotypes’ 204 
As with the microbiome, a considerable inter-individual variability in phage diversity is 205 
evident in human gut viromes studied to date (20,21,32). This variability is exemplified 206 
by the analysis conducted by Reyes et al, who evaluted the representation of highly 207 
abundant phage genomes (partial and complete) assembled from metagenomic reads 208 
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(88 in total), revealing that only 8 were found in more than one individual (20). This 209 
high person-to-person variability most likely stems from the ability of phage to undergo 210 
rapid evolution to form new virotypes (45), and the associated inter-personal variability 211 
of host bacterial species within the gut microbiome (5). In contrast, studies focusing 212 
on the microbiome in early infancy have indicted the virome to be low in diversity but 213 
highly dynamic during the very early developmental stages (26). Using 214 
epifluorescence microscopy, viral particles were found to be absent in the first stool 215 
samples from infants, but rapidly appear in the gut and reached levels of up to 216 
108 particles per gram of faeces by the end of the first week of life (26). A shift in 217 
microbiome structure and reduction in species diversity is also now well documented 218 
in elderly individuals, but there is currently a paucity of information regarding the gut 219 
virome structure in old age, and whether constituent phage may be involved in 220 
changes to the gut community seen with ageing.  221 
 222 
Despite the inter-individual differences in adult gut microbiomes and phageomes, the 223 
structure of the gut phageome can converge due to diet (21) and individuals (related 224 
or unrelated) who live in the same household will share a certain proportion of their 225 
gut virome, raising the potential for viral transmission between individuals in close 226 
contact (62). More recently, however, a conservation of virotypes in multiple 227 
individuals of diverse geographical origin (32,51,52,63) has been detected leading to 228 
the hypothesis of a core phageome in healthy individuals (42,63). Despite the reported 229 
high level of individuality between human gut viromes (20,21), a set of  23 ‘core’ 230 
phages have been identified within more than half of (geographically dispersed) 231 
individuals surveyed (n= 62) (63). 232 
 233 
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Such shared patterns of phage distribution have opened up the possibility of the 234 
existence of viral “enterotypes” (32), akin to observations from the bacterial component 235 
of the human gut microbiome, in which multiple individuals could be stratified 236 
according to their gut microbial composition into several “enterotypes” (7). As further 237 
studies and data accumulate, the nature of, or indeed the existence of these putative 238 
enterotypes will be resolved (32,64). Nevertheless, consideration of the human gut 239 
phageome should be an integral part of investigations that focus on defining structural 240 
or functional aspects of the gut microbiome, and their relevance to human health 241 
(32,64).  242 
 243 
Functional capacity within the phageome and potential for modulation of host-244 
microbiome interactions 245 
The idea that phage can also play a role in the health status of individuals by 246 
influencing microbiome structure or the phenotypes of host bacterial species, has also 247 
started to emerge (41,42,65,47,66). Significant shifts in community structure, including 248 
the balance of lytic versus lysogenic phage (see (42), for insightful discussion of this 249 
topic), have been observed in conditions such as inflammatory bowel diseases, 250 
autoimmunity, leukaemia and diabetes (67–71). How phage may contribute to 251 
modifications of underlying bacterial communities, and shifts from equilibrium with the 252 
human host to sub-optimal, unhealthy, or pathogenic interactions, is a subject of 253 
intense investigation and is comprehensively reviewed by De Paepe and colleagues 254 
(47).  255 
 256 
In one scenario, bacterial dysbiosis may result from environmental stressors triggering 257 
prophage induction more often in mutualistic bacteria than opportunistic pathogens 258 
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shifting the ratio of these bacterial types, termed the ‘community shuffling hypothesis’ 259 
(66). Phage within the gut also have the potential to modulate the immune response, 260 
either indirectly by modifying bacterial antigens or directly if phage particles are 261 
phagocytosed or infiltrate the intracellular environment (47,71,72). Additionally, a 262 
potentially unique role in gut health has also been highlighted for phage by recent work 263 
in mice revealing that the bacterial and virome components of the murine gut exhibited 264 
distinct responses to dietary intervention (73), results that the authors note are 265 
reminiscent of responses noted in Crohn’s disease patients (69). 266 
 267 
There is also considerable potential for phage to augment the functional repertoire of 268 
species comprising the microbiome, and confer particular advantages and new 269 
capabilities to host species or strains. This in turn could influence the interaction of 270 
these species with the human host, or their competitive fitness within the gut 271 
microbiome. Analysis of data generated from human-gut derived VLP libraries, as well 272 
as phage-orientated dissection of whole community gut metagenomes, has identified 273 
a broad functional potential ranging from bacteriocins, lysins, holins, restriction 274 
modification systems, virulence factors, genes associated with energy transfer and 275 
key biosynthetic pathways in bacterial hosts, as well as antibiotic resistance genes 276 
(20,21,25,26,31,32,74). A functional repertoire that places phage alongside other 277 
mobile genetic elements such as plasmids, with regard to the potential to introduce 278 
new traits to their bacterial hosts and develop new functional capacity. The ability of 279 
temperate phage to form long-term genetic symbioses with their host bacteria, inserted 280 
as prophage within host chromosomes, is likely to be an important source of genetic 281 
variation and diversity within the human gut, driving genetic exchange and altering 282 
phenotypes via lysogenic conversion. The apparent dominance of the temperate 283 
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lifestyle within the gut therefore has profound implications for community development 284 
and evolution (as outlined in Table 1), as well as functional capacity of gut microbes 285 
(23,75,76).  286 
 287 
There are numerous examples from studies of pathogenic gut bacteria, of phage 288 
facilitating the transfer of genetic material and/or encoding functions that may be 289 
beneficial for their host bacteria. This includes the wide range of phage-encoded 290 
virulence factors and toxins encoded by prophage (77) that lead to major infectious 291 
diseases. A particularly pertinent example to the gut ecosystem is the emergence of 292 
shiga toxin producing enteropathogenic E. coli strains that can cause severe disease, 293 
in which toxin production has been acquired through infection with lysogenic phage 294 
(78).  295 
 296 
A number of studies are now also revealing a diverse and significant phage-encoded 297 
antibiotic resistance gene pool within the human gut (20,21,79), which has been 298 
shown to be viable, mobile (31) and widely distributed within multiple individuals of 299 
diverse geographical origin (32). Moreover the importance of phage and the 300 
mechanisms used for acquiring and distributing antibiotic resistance genes has also 301 
been highlighted (80,81). Nevertheless, the true extent of the phage-encoded 302 
antibiotic resistance pool needs to be charted in a systematic and stringent manner.  303 
 304 
In this context, Enault and colleagues (82) have suggested that the use of non-305 
conservative thresholds within many bioinformatic-based surveys may have led to vast 306 
overestimates of phage-encoded antibiotic resistance genes in virome studies. The 307 
authors argue that the main route of transfer will be via generalised transduction, which 308 
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relies on errors in the packaging of non-phage DNA, intrinsically limiting the role of 309 
phage in dissemination of these genes to movement between species or strains 310 
infected by the transducing phage (82). How these observations can be reconciled 311 
with the reported expansion of the phage resistome following antibiotic perturbation 312 
((31); see also Community-level functions of the gut phageome), has yet to be 313 
determined. However, it is clear that further investigations of the mechanisms of 314 
phage-encoded gene transfer of clinically important traits such as antibiotic resistance 315 
are required to provide a more cohesive view of gene transfer and phage-bacteria 316 
interactions within the gut. Such studies will be inevitably aided by the isolation and 317 
genomic characterisation of phage originating from the human gut and in particular 318 
those infecting key members of this microbiome. 319 
 320 
Aside from the acquisition of accessory functions, such as virulence or antibiotic 321 
resistance genes, phage also have the potential to influence strain-strain competition 322 
within the gut ecosystem by facilitating the elimination of strains that would otherwise 323 
compete with bacterial hosts for resources. This derives from situations where 324 
prophage confer immunity to host strains from further infections by the same or closely 325 
related phage (30; Table 1). This contribution of phage to strain-strain competition 326 
could also play a role in facilitating maintenance of particular strains within the gut 327 
microbiome, or potentially in the ability of less desirable strains to displace beneficial 328 
members of the gut community. An elegant example of phage-mediated inter-strain 329 
warfare has recently been described in Enterococcus faecalis V583 (30). Prophage 330 
carried by this human gut colonising strain have been found to be crucial in allowing it 331 
to persist in the intestine, and avoid competitive exclusion by other strains. In this case, 332 
the prophage carried by V583 produces a constitutive low-level shedding of viral 333 
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particles from the host cell (also referred to as a chronic replication cycle). The phage 334 
particles release by V583 can infect and kill competing strains, but V583 host cells are 335 
rendered immune by virtue of their prophage lysogen (30). Alternatively, carriage of 336 
cryptic phages – a prophage that has lost the ability to enter the lytic cycle or produce 337 
phage particles – can be beneficial for surviving adverse conditions. The carriage of 338 
cryptic phage by E.coli enables the host bacterium to withstand multiple stressors such 339 
as oxidative, pH and antibiotic stressors and influences growth and biofilm formation 340 
(83; Table 1).  341 
 342 
Community-level functions of the gut phageome  343 
There is also considerable interest in the potential for the human gut phageome to play 344 
important and fundamental roles in the maintenance of a stable gut microbiome, and 345 
the scope for these viruses to provide direct benefits to the human host, outside of 346 
those that may be gained indirectly through effects on the bacterial gut community (as 347 
summarised in Table 1; see (84) for discussion of the beneficial impacts of viruses). 348 
 349 
The potential for phage to contribute to adaptability and recovery of the gut microbiome 350 
has been recently highlighted by Modi and co-workers, who detail the functional 351 
resilience of the community following antibiotic exposure (31). Gut-derived phage 352 
metagenomes from mice subjected to stress in the form of antibiotic treatment, were 353 
enriched in genes encoding functions involved in host metabolism, such as 354 
metabolism of cofactors and vitamins, as well as carbohydrate degrading enzymes 355 
and antibiotic resistance determinants. The authors suggested that this phage-356 
encoded accessory gene pool could act as a community-based mechanism to 357 
preserve the functional robustness of the gut microbiome during perturbation, acting 358 
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as a buffer of functions that are essential for the host-microbe relationship and that 359 
may become depleted during insults such as antibiotic treatment. The perturbation 360 
also led to a reported expansion of interactions between phage and bacteria that would 361 
likely increase the possibility of gene exchange, and further affirm the well-known role 362 
of phage in horizontal gene transfer. See Sun & Relman (85), for further analysis of 363 
this topic.   364 
 365 
Moving beyond the direct phage-bacteria co-evolutionary relationship, the potential for 366 
phage to directly enter into a symbiotic relationship with higher metazoan hosts has 367 
also been documented in some host-microbe relationships, and theorised to occur 368 
within the human gut (35,36; Table 1). In these phage-metazoan relationships, 369 
protecting or enhancing the fitness of the metazoan benefits the phage by maintaining 370 
the habitat, and therefore population, of host bacterial species in which it replicates. A 371 
good example of this co-evolutionary triangle has been identified through studies of 372 
the aphid symbiont Hamiltonia defensa (36), which confers protection to aphid hosts 373 
from attack by parasitoid wasps. Detailed analyses of this symbiosis has revealed the 374 
toxins responsible for the H. defensa protective effect are encoded by lysogenic phage 375 
that infect this species, and strains of H. defensa lacking this phage lysogen provide 376 
no protective effect (36).  377 
 378 
In the context of the human gut microbiome and associated virome, hypotheses for 379 
how this collection of phage may conceivably provide direct benefits to the human host 380 
are also emerging. The apparent enrichment of phage in the mucus layer covering 381 
intestinal epithelial cells in the mammalian gut, has led Barr and co-workers (35) to 382 
propose that phage accumulating in this region may provide important benefits for the 383 
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host by controlling the bacterial population in the mucus layer, and potentially providing 384 
protection from pathogens. Within this theory, phage embedded within the intestinal 385 
mucus layer are essentially hypothesised to provide a form of “non-host-derived 386 
immunity”, and enter into a direct symbiosis with the higher mammalian host (35). If 387 
true, this function of the gut virome opens further routes though which gut-associated 388 
phage may not only influence aspects of human well-being, but also potentially 389 
aspects of development, and would suggest that understanding the capacity or 390 
potential for “viral dysbiosis” should be given the same emphasis as perturbation of 391 
the bacterial component of this community. An exhaustive review of the concepts and 392 
potential consequences of host-microbiome-virome co-evolution is beyond the scope 393 
of this review but we refer the reader to excellent reviews by (39,59).  394 
 395 
Applications 396 
 397 
Since their initial discovery in the early twentieth century independently by Frederick 398 
Twort in 1915 (86) and Felix d’Herelle in 1917 (87), phage have been viewed in terms 399 
of human application, in the first instance for their antimicrobial properties. There is a 400 
long history of lytic phage and their encoded products being used to kill pathogenic 401 
bacterial species, an approach currently entering a renaissance in this critical era of 402 
antibiotic resistance. See (88–91) for excellent discussions on the topic. In the context 403 
of biotechnological and biomedical applications, phage also have a long history as 404 
work horses of molecular biology research, as well as delivery vehicles for vaccines 405 
and gene therapy (92). As our ability to chart and characterise the human gut 406 
phageome (and virome as a whole) continues, however, new biomedical and 407 
biotechnological avenues of application are being pursued.  408 
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 409 
Recognition that dysbiosis may also incorporate the phage component of the human 410 
gut ecosystem also opens up novel options for using phage as prognostic or predictive 411 
markers of disease (41,43). The notion that individuals could be stratified according to 412 
their virome structure (32) creates potential to develop diagnostics, prognostics and 413 
treatment approaches (64), expanding the microbiome for personalised medicine 414 
applications (7,93).  In tandem, the idea that phage have the potential to contribute to 415 
recovery and resilience of a gut community following perturbation (23,31) forms the 416 
foundation of using virome components for targeted interventions. In this context there 417 
has been much interested in the genetic engineering of phage for microbiome 418 
restructuring and selective elimination of bacterial strains (94–96).   419 
 420 
The specificity of phage for the human gut (38,97) can also be leveraged for the 421 
development of microbial source tracking tools (MST), which permit detection of faecal 422 
pollution in surface and ground waters. Faecal contamination poses a significant risk 423 
to human health and therefore there has been much interest in developing rapid and 424 
sensitive culture-independent methods that can detect human faecal indicator phage 425 
within environmental samples. Phage persist longer in the environment than host 426 
bacteria and often at higher numbers making them a potentially more sensitive source 427 
tracking tool (98–101). In tandem with improvements in next generation sequencing 428 
technologies, there is also potential to develop metagenomic approaches to MST, e.g. 429 
(102,103).The combination of MST with the high resolution provided by 430 
metagenomics.-based analysis of whole microbial communities potentially enabling 431 
identification of habitat associated genetic patterns – or an ecogenomic signature - 432 
that could be used to differentiate ecosystems. 433 
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 434 
Conclusions  435 
Knowledge around the human gut virome is now accumulating at an increasingly rapid 436 
pace. In particular next generation sequencing technologies have given us the ability 437 
to access the human gut phageome (and virome in general), to gain fundamental 438 
insight into the form and function of this viral assemblage. Studies to date are revealing 439 
a diverse and abundant viral ecosystem that is being increasingly recognised as an 440 
important facet of the gut microbiome. As progress continues in our ability to 441 
characterise the human gut virome so does our ability to harness its power for 442 
biomedical and biotechnological application. Further understanding of the host-phage 443 
dynamic is crucial in moving the field forward, with more emphasis on temporal and 444 
multi-level studies that take a more inclusive view of the human gut virome, alongside 445 
the other components of the human gut microbiome. Integral to these efforts, and the 446 
more meaningful interpretation of data derived from metagenomic approaches to study 447 
the gut virome, will be continued efforts to pursue more traditional approaches to 448 
isolate, propagate, and characterise phage comprising the human gut phageome.    449 
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Summary Points 450 
 451 
• Advances in next generation sequencing technologies are allowing us to 452 
illuminate the human gut virome, the diverse and abundant collection of viruses 453 
associated with the human gut microbiome.  454 
 455 
• We focus here on the form and function of the viruses infecting bacteria 456 
(bacteriophage or phage), which are a dominant component of the human gut 457 
virome. 458 
 459 
• Key points of discussion include the potential role of the ‘phageome’ in driving 460 
ecological functioning and evolutionary change with the human gut microbiome 461 
and how they could contribute to modulation of host-microbiome interactions 462 
and stability of the community as a whole, as well as their potential role in health 463 
and disease. 464 
 465 
• Emerging concepts of a ‘core healthy gut phageome’, the putative existence of 466 
‘viral enterotypes’ and ‘viral dysbiosis’ are considered.    467 
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Box 1  468 
Glossary 
 
Bacteriophage Viruses which infect and complete their life cycle within bacterial cells 
 
Human gut 
virome 
 
The collection of viruses associated with the human gut microbiome  
 
Phageome The genetic composition of the bacteriophage fraction of a microbial 
community 
  
Prophage  Term to describe a phage genome which is integrated into a bacterial 
chromosome. Can also exist externally to the bacterial chromosome 
as an episomal element. The prophage is a non-infective precursor 
phage.  
  
Temperate  When phage have the ability to enter a lysogenic cycle of replication.   
  
Lysogeny  
 
Ability of phage to integrate into host bacterium DNA to become a 
prophage. The prophage is copied each time the bacterial cell divides.   
 
Lysogenic 
conversion 
 
Expression of prophage genes within the host genome affecting the 
phenotype of the host cell.  
 
Composite  
phage  
 
A phage derived from two distinct chromosomally encoded prophage 
elements 
  469 
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